Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1/2 1

Status

Unknown 1Terminated 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 4OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Carcinoma, Non-Small-Cell Lung 242Lung Neoplasms 59Neoplasms 57Head and Neck Neoplasms 57Stomach Neoplasms 56Squamous Cell Carcinoma of Head and Neck 48Parkinson Disease 4, Autosomal Dominant Lewy Body 44Neoplasm Metastasis 40Small Cell Lung Carcinoma 38Urinary Bladder Neoplasms 28Uterine Cervical Neoplasms 26Esophageal Neoplasms 25Colorectal Neoplasms 24Cholangiocarcinoma 24Biliary Tract Neoplasms 24Carcinoma 23Ovarian Neoplasms 21Carcinoma, Transitional Cell 18Carcinoma, Squamous Cell 17Recurrence 16Esophageal Squamous Cell Carcinoma 16Melanoma 13Breast Neoplasms 13Non-Squamous Non-Small Cell Lung Cancer 12Mesothelioma, Malignant 12Mesothelioma 12Nasopharyngeal Carcinoma 11Endometrial Neoplasms 11Adenocarcinoma 11Gallbladder Neoplasms 10

Interventions

Cisplatin 4Carboplatin 2viscum album peptide 1sugemalimab 1rilotumumab 1ganitumab 1endostar protein 1Zoledronic Acid 1Valacyclovir 1Thiostrepton 1Surgical Procedures, Operative 1Paclitaxel 1N-(5-(2,3-dihydrobenzofuryl)sulfonyl)-N'-(3,4-dichlorophenyl)urea 1Etoposide 1Darbepoetin alfa 1Cetuximab 1Catheters, Indwelling 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Pleural Effusion, Malignant × Cisplatin × Clear all
NCT04914598 2026-01-02

A Phase â…¢ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural Effusions

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 3 Active not recruiting
290 enrolled
Thoracic

Pleural Effusion, Malignant

NCT00791154 2024-08-23

SCLC

NantCell, Inc.

Phase 1/2 Terminated
213 enrolled 16 charts
Thoracic

Lung Neoplasms, Pleural Effusion, Malignant, Small Cell Lung Carcinoma

NCT02429726 2015-04-29

Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion

Shenzhen SiBiono GeneTech Co.,Ltd

Phase 2 Unknown
90 enrolled
Thoracic

Pleural Effusion, Malignant

NCT01327235 2014-08-01

Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 2 Completed
336 enrolled
Thoracic

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡